Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma
Authors
Keywords
OSCC, Kallikrein 5, LEKTIb, SPINK5, Prognostic marker
Journal
Translational Oncology
Volume 14, Issue 1, Pages 100970
Publisher
Elsevier BV
Online
2020-11-29
DOI
10.1016/j.tranon.2020.100970
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel tumor suppressor SPINK5 targets Wnt/β-catenin signaling pathway in esophageal cancer
- (2019) Qian Wang et al. Cancer Medicine
- PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma
- (2019) Honghai Ma et al. Scientific Reports
- Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma
- (2018) Liang Zhong et al. BMC CANCER
- The kallikrein-related peptidase family: Dysregulation and functions during cancer progression
- (2016) T. Kryza et al. BIOCHIMIE
- Kallikreins – The melting pot of activity and function
- (2016) Magdalena Kalinska et al. BIOCHIMIE
- Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models
- (2016) J.A. McGovern et al. BRITISH JOURNAL OF DERMATOLOGY
- Kallikrein-related peptidases (KLKs) and the hallmarks of cancer
- (2016) Panagiota S. Filippou et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma
- (2016) Jeff J. Johnson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oral cavity and oropharyngeal squamous cell carcinoma-an update
- (2015) Angela C. Chi et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Co-Expression of Kallikrein 5 and Kallikrein 7 Associates with Poor Survival in Non-HPV Oral Squamous-Cell Carcinoma
- (2015) Frank K.J. Leusink et al. PATHOBIOLOGY
- Improved vectors and genome-wide libraries for CRISPR screening
- (2014) Neville E Sanjana et al. NATURE METHODS
- DNA targeting specificity of RNA-guided Cas9 nucleases
- (2013) Patrick D Hsu et al. NATURE BIOTECHNOLOGY
- Validation of a Gene Expression Signature for Assessment of Lymph Node Metastasis in Oral Squamous Cell Carcinoma
- (2012) Sander R. van Hooff et al. JOURNAL OF CLINICAL ONCOLOGY
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
- (2010) Peter Goettig et al. BIOCHIMIE
- Kallikrein-5 Promotes Cleavage of Desmoglein-1 and Loss of Cell-Cell Cohesion in Oral Squamous Cell Carcinoma
- (2010) Rong Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites
- (2010) Avraham Zini et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome
- (2010) Katiuchia Uzzun Sales et al. NATURE GENETICS
- Functional Roles of Human Kallikrein-related Peptidases
- (2009) Georgia Sotiropoulou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper
- (2008) Mette Munk Jensen et al. BMC MEDICAL IMAGING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started